Alphanate
NDC Package 68516-4613-2
Package Information
Alphanate is indicated for:Treatment and prevention of bleeding episodes and perioperative management in adult and pediatric patients with Factor VIII (FVIII) deficiency due to hemophilia A.Perioperative management in adult and pediatric patients with Type 1 and Type 2 von Willebrand Disease (VWD) in whom desmopressin (DDAVP) is either ineffective or contraindicated.Perioperative management in minor surgery in adult and pediatric patients with Type 3 VWD. Marketed by Grifols Usa, Llc, this product is identified by NDC 68516-4613 and is authorized under FDA application BLA102475.
Identification & Billing
- RxCUI: 1661332 - antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection
- RxCUI: 1661332 - factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection
- RxCUI: 1661332 - factor VIII / von Willebrand Factor complex, human 1 UNT Injection
- RxCUI: 1661345 - Alphanate (expressed as von Willebrand factor) 1 UNT Injection
- RxCUI: 1661345 - factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection [Alphanate]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68516 - Grifols Usa, Llc
- 68516-4613 - Alphanate
- 68516-4613-2 - 1 KIT in 1 CARTON * 10 mL in 1 VIAL, SINGLE-DOSE (68516-1002-2) * 10 mL in 1 VIAL (68516-4607-2)
- 68516-4613 - Alphanate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68516-4613-2 identifies a specific commercial package of 1 kit in 1 carton * 10 ml in 1 vial, single-dose (68516-1002-2) * 10 ml in 1 vial (68516-4607-2) of Alphanate, labeled by Grifols Usa, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Grifols Usa, Llc on August 15, 1978. The current certification is valid through February 29, 2024.
How is this Grifols Usa, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68516461302. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.